PLAG1 alterations in lipoblastoma -: Involvement in varied mesenchymal cell types and evidence for alternative oncogenic mechanisms

被引:103
作者
Gisselsson, D
Hibbard, MK
Dal Cin, P
Sciot, R
Hsi, BL
Kozakewich, HP
Fletcher, JA
机构
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Dept Pediat, Boston, MA 02115 USA
[4] Dana Farber Canc Inst, Dept Adult Oncol, Boston, MA 02115 USA
[5] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA
[6] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[7] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA
[8] Univ Hosp, Dept Clin Genet, Lund, Sweden
[9] Univ Hosp, Dept Pathol, Louvain, Belgium
关键词
D O I
10.1016/S0002-9440(10)61771-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Lipoblastomas are rare soft tissue tumors that occur primarily in young children. They typically contain variably differentiated adipocytes, primitive mesenchymal cells, myxoid matrix, and fibrous trabeculae. Abnormalities in chromosome 8, leading to rearrangements of the PLAG1 gene, were demonstrated recently in four lipoblastomas. In the present report, we determine the frequency of PLAG1 alterations in 16 lipoblastomas from children aged 13 years or younger, and we also evaluate the stages of lipoblastoma differentiation at which PLAG1 genomic alterations are found. Eleven lipoblastomas (69%), including those with either classic or lipoma-like histology, had rearrangements of the 8q12 PLAG1 region. Another three lipoblastomas had polysomy for chromosome 8 In the absence of PLAG1 rearrangement. Only two cases (13%) lacked a chromosome 8 abnormality. Notably, the lipoblastomas with chromosome 8 polysomy had up to five copies of chromosome 8 as an isolated cytogenetic finding in an otherwise diploid cell. We also demonstrate that PLAG1 alterations are found in a spectrum of mesenchymal cell types in lipoblastomas, including lipoblasts, mature adipocytes, primitive mesenchymal cells, and fibroblastlike cells. This finding is consistent with neoplastic origin in a primitive mesenchymal precursor and with variable differentiation to a mature adipocyte end-point. Hence, our studies provide biological validation for the clinical observation that lipoblastomas can evolve into mature, lipoma-like, lesions. They also suggest that PLAG1 dosage alterations caused by polysomy 8 might represent an alternative oncogenic mechanism in lipoblastoma.
引用
收藏
页码:955 / 962
页数:8
相关论文
共 28 条
[1]   Human translocation liposarcoma CCAAT enhancer binding protein (C/EBP) homologous protein (TLS-CHOP) oncoprotein prevents adipocyte differentiation by directly interfering with C/EBPβ function [J].
Adelmant, G ;
Gilbert, JD ;
Freytag, SO .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) :15574-15581
[2]   Fusion genes in solid tumors [J].
Åman, P .
SEMINARS IN CANCER BIOLOGY, 1999, 9 (04) :303-318
[3]  
ASHAR HR, 1995, CELL, V82, P57
[4]  
Åström AK, 2000, INT J ONCOL, V16, P1107
[5]   POINT MUTATIONS IN THE C-MYC TRANSACTIVATION DOMAIN ARE COMMON IN BURKITTS-LYMPHOMA AND MOUSE PLASMACYTOMAS [J].
BHATIA, K ;
HUPPI, K ;
SPANGLER, G ;
SIWARSKI, D ;
IYER, R ;
MAGRATH, I .
NATURE GENETICS, 1993, 5 (01) :56-61
[6]  
COFFIN CM, 1994, SEMIN DIAGN PATHOL, V11, P98
[7]   Lipoblastoma/lipoblastomatosis: A clinicopathologic study of 25 tumors [J].
Collins, MH ;
Chatten, J .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1997, 21 (10) :1131-1137
[8]   FUSION OF CHOP TO A NOVEL RNA-BINDING PROTEIN IN HUMAN MYXOID LIPOSARCOMA [J].
CROZAT, A ;
AMAN, P ;
MANDAHL, N ;
RON, D .
NATURE, 1993, 363 (6430) :640-644
[9]   CYTOGENETIC AND FLUORESCENCE IN-SITU HYBRIDIZATION INVESTIGATION OF RING CHROMOSOMES CHARACTERIZING A SPECIFIC PATHOLOGICAL SUBGROUP OF ADIPOSE-TISSUE TUMORS [J].
DALCIN, P ;
KOOLS, P ;
SCIOT, R ;
DEWEVER, I ;
VANDAMME, B ;
VANDEVEN, W ;
VANDENBERGHE, H .
CANCER GENETICS AND CYTOGENETICS, 1993, 68 (02) :85-90
[10]   NEW DISCRIMINATIVE CHROMOSOMAL MARKER IN ADIPOSE-TISSUE TUMORS - THE CHROMOSOME 8Q11-Q13 REGION IN LIPOBLASTOMA [J].
DALCIN, P ;
SCIOT, R ;
DEWEVER, I ;
VANDAMME, B ;
VANDENBERGHE, H .
CANCER GENETICS AND CYTOGENETICS, 1994, 78 (02) :232-235